// App-Quantinova.ai

PB0935 : Real World Efficacy of Emicizumab in Haemophilia A with Inhibitors: A Report from the UK National Haemophilia Database

Researchers

Presenter

  • C. Wall

Principal Investigators

  • H. Xiang

  • B. Palmer

  • P. Collins

  • D. Hart

  • G. Hall

  • E. Chalmers

  • G. Benson

  • G. Evans

  • R. Liesner

  • M. Makris

  • C. Harrison

  • S. Mangles

  • R. Maclean

  • S. Shapiro

  • D. Stephensen

  • P. Sartain

  • C. Hay

Medical Centers

  • Manchester Royal Infirmary, Manchester, United Kingdom

  • UK National Haemophilia Database, Manchester, United Kingdom

  • University Hospital of Wales, Cardiff, United Kingdom

  • The Royal London Hospital Haemophilia Centre, Barts and the London School of Medicine and Dentistry, QMUL, London, UK

  • John Radcliffe Hospital, Oxford, United Kingdom.

  • Royal Hospital for Sick Children, Glasgow, United Kingdom

  • Belfast City Hospital, Belfast, United Kingdom

  • Kent & Canterbury Hospital, Kent, United Kingdom

  • Great Ormond Street Hospital, London, United Kingdom

  • Royal Hallamshire Hospital, Sheffield, United Kingdom

  • Basingstoke and North Hampshire Hospital, Basingstoke, United Kingdom

  • Oxford University Hospitals NHS Trust, Oxford, United Kingdom

  • UKHCDO Data Analysis Group, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved